Results 221 to 230 of about 134,700 (260)
Some of the next articles are maybe not open access.

Intensive chemotherapy for peripheral T‐cell lymphomas

Hematological Oncology, 1992
AbstractForty‐two patients with previously untreated peripheral T‐cell lymphomas (PTCL) were treated with an intensive chemotherapy protocol. Either the BACOP or the m‐BACOD regimen was used for induction. Patients achieving complete clinical remission after three courses were given intensive consolidation and maintenance chemotherapy similar to the ...
Liang, R   +6 more
openaire   +4 more sources

The prognostic factors for peripheral T‐cell lymphomas

Hematological Oncology, 1992
AbstractThe peripheral T‐cell lymphomas of 50 patients were classified by histological type and tumour cell size, the latter as described by the Nebraska Group. There was no difference in the pattern of their clinical features among the various histological subtypes and their clinical outcome was similar. Cell size and other factors including sex, age,
Liang, R, Loke, SL, Chan, ACL
openaire   +4 more sources

Peripheral T-cell lymphoma – Not otherwise specified

Critical Reviews in Oncology/Hematology, 2011
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) does correspond to a heterogeneous group of nodal and extranodal mature T-cell lymphomas, with a low prevalence in Western countries. PTCL-NOS accounts for about 25% of all PTCL, which represent over 15% of all lymphomas. In the lymph node, PTCL-NOS shows paracortical or diffuse infiltrates
Savage KJ   +3 more
openaire   +3 more sources

Update: Peripheral T-Cell Lymphomas

Current Hematologic Malignancy Reports, 2011
Peripheral T-cell lymphomas (PTCLs) are a group of biologically heterogeneous but typically aggressive diseases. Progress in understanding and developing optimal therapies for PTCLs has been hampered by disease rarity and only relatively recent recognition of the importance of the T-cell phenotype.
openaire   +2 more sources

Pathobiology of Peripheral T-cell Lymphomas

Hematology, 2006
AbstractPeripheral T-cell lymphomas (PTLs) are uncommon, accounting for fewer than 10% of all non-Hodgkin lymphomas. Success in therapy of the PTLs has lagged behind that of aggressive B-cell lymphomas, and most PTLs have a poor prognosis. The molecular pathogenesis of most PTLs is also poorly understood.
openaire   +2 more sources

Peripheral T-cell lymphomas

Hématologie, 2014
Les lymphomes T peripheriques (LTP) sont des maladies tumorales lymphoides qui derivent des cellules T ou natural killer (NK). C’est un groupe heterogene representant 10-15 % des lymphomes non hodgkiniens (LNH), soit environ 1 300 nouveaux cas par an en France. Malgre leur faible frequence, ils sont d’une grande diversite.
Olivier Tournilhac   +2 more
openaire   +1 more source

Peripheral T cell lymphoma.

Journal of Clinical Oncology, 1987
Thirty-one Chinese patients with peripheral T cell lymphoma (PTCL) were reviewed. Using the modified Japanese Lymphoma Group classification, there were nine (29%) of the pleomorphic type, 16 (52%) immunoblastic lymphadenopathy (IBL)-like, two (7%) T-zone lymphoma, and one (3%) Lennert's lymphoepithelioid type. Three (9%) were not classifiable.
R, Liang   +5 more
openaire   +2 more sources

Peripheral T-Cell Lymphomas

2016
Nodal peripheral T cell lymphomas (TCL) are rare entities with poor prognosis including ALK+ and ALK- systemic anaplastic T-cell lymphoma (ALCL), angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma – not otherwise specified. The role of PET in TCL is less well established compared to other lymphoma entities.
Maria K. Angelopoulou   +2 more
openaire   +1 more source

Peripheral T-Cell Lymphoma of the Pleura

American Journal of Respiratory and Critical Care Medicine, 2014
Timothy M, Saettele   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy